Calidi Biotherapeutics to Present at Jefferies Healthcare Conference
yahoo.com
news
2022-06-02 12:00:00

LA JOLLA, Calif., June 02, 2022--(BUSINESS WIRE)--Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company pioneering the development of stem cell-based delivery of oncolytic viruses, today announced that Stephen Thesing, Chief Business Officer, will present a company overview at the Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 2:00 p.m. ET. The conference will be taking place June 8-10, 2022 in New York City.

About Calidi Biotherapeutics

Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology that is revolutionizing the effective delivery of oncolytic viruses for targeted therapy against difficult-to-treat cancers.
